Redefining Normal

Machine learning models can help identify personal blood count ranges to more accurately monitor a patient’s health.

Computer Medicine Technology

Current Issue

This Article From Issue

March-April 2025

Volume 113, Number 2
Page 72

DOI: 10.1511/2025.113.2.72

Ad Left

If you’ve ever had a doctor order a blood test for you, chances are they ran a complete blood count, or CBC. One of the most common blood tests in the world, CBC tests are run billions of times each year to diagnose conditions and monitor patients’ health.

But despite the test’s ubiquity, the way clinicians interpret and use it in the clinic is often less precise than is ideal. Currently, blood test readings are based on one-size-fits-all reference intervals that don’t account for individual differences.

I am a mathematician at the University of Washington School of Medicine, and my team studies ways to use computational tools to improve clinical blood testing. To develop better ways to capture individual patient definitions of “normal” lab values, my colleagues at the Higgins Lab at Harvard Medical School and I examined 20 years of blood count tests from tens of thousands of patients.

In our newly published research, we used machine learning to identify healthy blood count ranges for individual patients and to predict their risk of future disease.

Clinical Tests and Blood Counts

People commonly think of clinical tests as purely diagnostic. For example, a test for COVID-19 or for pregnancy comes back as either positive or negative, telling you whether you have a particular condition. However, most tests don’t work this way. Instead, they measure a biological trait that your body continuously regulates up and down to stay within certain bounds.

Your complete blood count is also a continuum. The CBC test creates a detailed profile of your blood cells—such as how many red blood cells, platelets, and white blood cells are in your blood. These markers are used every day in nearly all areas of medicine.

For example, hemoglobin is an iron-containing protein that allows your red blood cells to carry oxygen. If your hemoglobin levels are low, it might mean you are iron deficient. Platelets are cells that help form blood clots and stop bleeding. If your platelet count is low, it may mean you have internal bleeding and your body is using platelets to help form blood clots to plug the wound. White blood cells are part of your immune system. If your white blood cell count is high, it might mean you have an infection and your body is producing more of these cells to fight it off.

Not-So-Normal Ranges

But these various tests and measures all raise the question: What actually counts as too high or too low on a blood test?

We could note when someone’s result was outside their smaller personal range, potentially indicating an issue, even if the result was within the normal range for the population overall.

Traditionally, clinicians determine what are called reference intervals by measuring a blood test in a range of healthy people. They usually take the middle 95 percent of these healthy values and call that “normal,” with anything above or below being deemed too low or too high. These normal ranges are used nearly everywhere in medicine. But reference intervals face a big challenge: What’s normal for you may not be normal for someone else.

Nearly all blood count markers are heritable, meaning your genetics and environment determine much of what the healthy value for each marker is for you. At the population level, for example, a normal platelet count is approximately between 150 billion and 400 billion cells per liter of blood. But your body may want to maintain a platelet count of 200 billion platelets per liter of blood—a value called your set point—which means your normal range might only be from 150 billion to 250 billion.

Differences between a patient’s true normal range and the population-based reference interval can create problems for doctors, who may be less likely to diagnose a disease if the patient’s set point is far from a cutoff. Conversely, they may run unnecessary tests if the set point is too close to a cutoff.

Defining What’s Normal for You

Luckily, many patients get blood counts each year as part of routine checkups. Using machine learning models, my team and I were able to estimate blood count set points for more than 50,000 patients based on their histories of visits to the clinic. This process allowed us to study how the body regulates these set points and to test whether we can build better ways of personalizing lab test readings.

Over multiple decades, we found that individual normal ranges were about three times smaller than those measured at the population level. For example, while the “normal” range for the white blood cell count is from 4 billion to 11 billion cells per liter of blood, we found that most people’s individual ranges were much narrower, such as from 4.5 billion to 7 billion, or from 7.5 billion to 10 billion. When we used these set points to interpret new test results, they helped improve diagnoses of diseases such as iron deficiency, chronic kidney disease, and hypothyroidism. We could note when someone’s result was outside their smaller personal range, potentially indicating an issue, even if the result was within the normal range for the population overall.

Javier LARREA/Alamy Stock Photo

The set points themselves were strong indicators for future risk of developing a disease. For example, patients with high white blood cell set points were more likely to develop type 2 diabetes in the future. They were also nearly twice as likely to die of any cause compared with similar patients with low white blood cell counts. Other blood count markers were also strong predictors of future disease and mortality risk.

In the future, doctors could potentially use set points to improve disease screening and how they interpret new test results. This avenue is an exciting development for personalized medicine: using your own medical history to define what exactly “healthy” means for you.

Bibliography

  • Billman, G. E. 2020. Homeostasis: The underappreciated and far too often ignored central organizing principle of physiology. Frontiers in Physiology 11:200.
  • Foy, B. H., et al. 2025. Haematological setpoints are a stable and patient-specific deep phenotype. Nature 637:430–438.
  • Horton, S., et al. 2019. The top 25 laboratory tests by volume and revenue in five different countries. American Journal of Clinical Pathology 151:446–451.
    • Mosley, J. D., et al. 2024. Clinical associations with a polygenic predisposition to benign lower white blood cell counts. Nature Communications 15:3384.
    • Prochazka, A. V., K. Lundahl, W. Pearson, S. K. Oboler, and R. J. Anderson. 2005. Support of evidence-based guidelines for the annual physical examination: A survey of primary care providers. Archives of Internal Medicine 165:1347–1352.
    • Vuckovic, D., et al. 2020. The polygenic and monogenic basis of blood traits and diseases. Cell 182:1214–1231.e11.

This article was originally published on theconversation.com.

American Scientist Comments and Discussion

To discuss our articles or comment on them, please share them and tag American Scientist on social media platforms. Here are links to our profiles on Twitter, Facebook, and LinkedIn.

If we re-share your post, we will moderate comments/discussion following our comments policy.